Pharma Face-Off: Eli Lilly, Novo Nordisk, and Merck Showdown

Investors are buzzing about three big pharma stars: Eli Lilly, Novo Nordisk, and Merck! Eli is flying high with a 48% revenue jump, thanks to its top drug. Novo is in a pickle with price cuts, while Merck is on a wild ride, waiting for big news in 2027. Who will take the crown in this financial showdown? Stay tuned!